Medical News

Frailty as a Novel Predictor of Achieving Comprehensive Dise...
Clin. Rheumatol.

Frailty, measured by CRAF, reduced the likelihood of CDC achievement in RA patients treated with a biologic agent...

21 Jul 2021

Primary and Revision Total Knee Arthroplasty in Patients wit...
J Arthroplasty

Patients with pulmonary HTN undergoing primary and revision TKAs had excess risk of death and experience a high...

20 Jul 2021

Red Cell Distribution Width: Commonly Performed Test Predict...
J Arthroplasty

RDW appears to be a useful parameter that, when combined with CCI, can predict the risk for 1-year mortality after...

15 Jul 2021

Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to...
JAMA.

Among patients with newly diagnosed ANCA-associated vasculitis without severe glomerulonephritis or alveolar...

09 Jul 2021

Key Trials

Long-term Efficacy and Safety of Alendronate in Adults with AVN

The present study is a systematic review evaluating long-term efficacy and safety of alendronate in adults with avascular osteonecrosis. The...

BREVACTA Study: Long-term Efficacy and Safety of Subcutaneous Tocilizumab Every 2 Weeks in RA Patients with Inadequate Response to DMARDs

BREVACTA study evaluated long-term efficacy and safety of subcutaneous tocilizumab (TCZ-SC) every 2 weeks (q2w) over 2 years in patients with...

SUMMACTA Trial: Long-term Efficacy and Safety of Subcutaneous Tocilizumab versus Intravenous Tocilizumab in Combination with Traditional DMARDs in Patients with RA

SUMMACTA Trial evaluated long-term efficacy and safety of subcutaneous tocilizumab versus intravenous TCZ, including switching formulations, in...

Benefits of Inhaled Budesonide in Early COVID-19 Infection: STOIC Study

This infographic summarises the key points of the STOIC study and outlines the benefits of administering inhaled budesonide in early COVID-19...

Patient Education

Systemic Lupus Erythematosus

Systemic Lupus Erythematosus (SLE) is an inflammatory disease caused when the immune system attacks body’s own tissues. This leaflet gives an overvie...

Food Rich in Calcium and Vitamin D

Eating foods rich in calcium and vitamin D may help prevent bones from becoming weak and less likely to fracture.  This article gives a list of food...

Calcium – Vitamin D Recommended Dietary Allowance

Calcium and vitamin D are two essential nutrients long known for their roles in maintaining bone health. This article gives comprehensive recommended...

Our Publications

Zotide (Teriparatide ) Monograph

The currently available pharmacological treatments for osteoporosis are predominantly anti-resorptive. These inhibit osteoclast-mediated bone loss...

Hyruan (Hyaluronic Acid) Monograph

Osteoarthritis (OA) is the most common form of arthritis and is a major cause of debilitation for affected individuals. One of the nonsurgical...

Calcinase (calcitonin) – Monograph

This monograph covers various aspects of osteoporosis management and pharmacology, clinical efficacy & safety of calcitonin in treatment of...

Imutrex (methotrexate) – Getting to the Heart of Rheumatoid Arthritis Abstracts Booklet

This publication features efficacy & safety studies of methotrexate in management of rheumatoid arthritis.

Slide Library

Intraarticular Hyaluronic acid for Osteoarthirits

The presentation includes description of synovial hyaluronic acid, its viscoelastic property, mechanism of action and different types available in...

 
Email this page
Osteoarthritis

This presentation shows the structure of bone joint majorly affected in osteoarthritis, its pathophysiology, risk factors, signs and symptoms and...

 
Email this page
Recommendations for Up & Downscaling of Methotrexate Dose in Rheumatoid Arthritis

Methotrexate (MTX) is the first-line treatment for early and clearly defined rheumatoid arthritis (RA). This presentation summarizes the...

 
Email this page
Musculoskeletal Manifestations of Ulcerative Colitis

This slide set covers the common musculoskeletal manifestations of inflammatory bowel diseases (IBD) and its management. The spectrum of these...

 
Email this page

Poll

Which of the following bisphosphonate is preferred as first line treatment of osteoporosis-

Alendronate
67% (4 votes)
Risedronate
0% (0 votes)
Ibandronate
0% (0 votes)
Zoledronic acid
33% (2 votes)
Total votes: 6